Beigene Ltd
ONC326.060USD
-2.650-0.81%
終値 09/26, 16:00（ET）15分遅れの株価
32.94B時価総額
損失額直近12ヶ月PER
詳細情報 企業名
企業情報
企業コードONC
会社名BeOne Medicines AG
上場日- -
最高経営責任者「CEO」Mr. John Victor Oyler
従業員数11000
証券種類Ordinary Share
決算期末- -
本社所在地c/o BeOne Medicines I GmbH
都市BASEL
証券取引所The Toronto Stock Exchange
国Switzerland
郵便番号4051
電話番号41616851900
ウェブサイト
企業コードONC
上場日- -
最高経営責任者「CEO」Mr. John Victor Oyler
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Xiaobin Wu, Ph.D.
Mr. Xiaobin Wu, Ph.D.
President, Chief Operating Officer, General Manager, China
President, Chief Operating Officer, General Manager, China
10.89K
--
Mr. Lai Wang
Mr. Lai Wang
Global Head of R&D
Global Head of R&D
--
--
MR. Aaron Rosenberg
MR. Aaron Rosenberg
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Olivier Brandicourt, M.D.
Dr. Olivier Brandicourt, M.D.
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Giancarlo Benelli
Mr. Giancarlo Benelli
Senior Vice President, Head of Europe
Senior Vice President, Head of Europe
--
--
Mr. Chan Lee, J.D.
Mr. Chan Lee, J.D.
Senior Vice President, General Counsel
Senior Vice President, General Counsel
--
--
Ms. Shalini Sharp
Ms. Shalini Sharp
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Xiaodong Wang, Ph.D.
Dr. Xiaodong Wang, Ph.D.
Co-Founder, Non-Executive Director
Co-Founder, Non-Executive Director
--
--
Dr. Han (Margaret) Dugan, M.D.
Dr. Han (Margaret) Dugan, M.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. John Victor Oyler
Mr. John Victor Oyler
Co-Founder, Executive Chairman of the Board, Chief Executive Officer
Co-Founder, Executive Chairman of the Board, Chief Executive Officer
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Xiaobin Wu, Ph.D.
Mr. Xiaobin Wu, Ph.D.
President, Chief Operating Officer, General Manager, China
President, Chief Operating Officer, General Manager, China
10.89K
--
Mr. Lai Wang
Mr. Lai Wang
Global Head of R&D
Global Head of R&D
--
--
MR. Aaron Rosenberg
MR. Aaron Rosenberg
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Olivier Brandicourt, M.D.
Dr. Olivier Brandicourt, M.D.
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Giancarlo Benelli
Mr. Giancarlo Benelli
Senior Vice President, Head of Europe
Senior Vice President, Head of Europe
--
--
Mr. Chan Lee, J.D.
Mr. Chan Lee, J.D.
Senior Vice President, General Counsel
Senior Vice President, General Counsel
--
--
収益内訳
通貨: USD更新時刻: Sun, Jul 6
通貨: USD更新時刻: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
事業別USD
会社名
収益
比率
Product
1.09B
97.61%
BRUKINSA
791.66M
70.86%
Tislelizumab
171.16M
15.32%
XGEVA
70.42M
6.30%
BLINCYTO
23.91M
2.14%
他の
-1.03B
-92.23%
地域別USD
会社名
収益
比率
United States
567.21M
50.77%
China
399.59M
35.76%
Europe
118.55M
10.61%
ROW
31.92M
2.86%
事業別
地域別
事業別USD
会社名
収益
比率
Product
1.09B
97.61%
BRUKINSA
791.66M
70.86%
Tislelizumab
171.16M
15.32%
XGEVA
70.42M
6.30%
BLINCYTO
23.91M
2.14%
他の
-1.03B
-92.23%
株主
更新時刻: 17 hours ago
更新時刻: 17 hours ago
株主統計
種類
株主統計
株主統計
比率
Amgen Inc
17.27%
Baker Bros. Advisors LP
8.02%
PRIMECAP Management Company
4.64%
Capital International Investors
4.45%
Fidelity Management & Research Company LLC
3.11%
他の
62.50%
株主統計
株主統計
比率
Amgen Inc
17.27%
Baker Bros. Advisors LP
8.02%
PRIMECAP Management Company
4.64%
Capital International Investors
4.45%
Fidelity Management & Research Company LLC
3.11%
他の
62.50%
種類
株主統計
比率
Investment Advisor
18.07%
Corporation
17.28%
Hedge Fund
9.62%
Investment Advisor/Hedge Fund
4.28%
Sovereign Wealth Fund
1.13%
Research Firm
0.63%
Bank and Trust
0.07%
Pension Fund
0.05%
Family Office
0.02%
他の
48.85%
機関投資家保有株
更新時刻: Tue, Jul 1
更新時刻: Tue, Jul 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q2
558
63.29M
57.54%
+456.15K
2025Q1
585
69.06M
63.84%
+3.36M
2024Q4
575
70.01M
71.38%
+1.65M
2024Q3
603
67.03M
68.90%
-2.04M
2024Q2
601
66.99M
69.35%
-2.19M
2024Q1
621
66.56M
67.86%
-955.35K
2023Q4
626
65.12M
66.49%
-3.71M
2023Q3
632
67.27M
67.88%
-2.05M
2023Q2
655
66.79M
67.58%
-3.13M
2023Q1
655
67.68M
71.16%
-4.10M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Amgen Inc
18.94M
17.28%
--
--
Feb 20, 2025
Baker Bros. Advisors LP
8.80M
8.03%
--
--
Mar 31, 2025
PRIMECAP Management Company
5.06M
4.61%
-43.40K
-0.85%
Mar 31, 2025
Capital International Investors
5.09M
4.64%
-1.02M
-16.72%
Mar 31, 2025
Fidelity Management & Research Company LLC
3.36M
3.07%
+1.58M
+88.38%
Mar 31, 2025
HHLR Advisors, Ltd.
1.03M
0.94%
--
--
May 09, 2025
Temasek Holdings Pte. Ltd.
993.75K
0.91%
-531.58K
-34.85%
Mar 31, 2025
T. Rowe Price International Ltd
1.30M
1.19%
-143.22K
-9.92%
Mar 31, 2025
Citadel Advisors LLC
982.16K
0.9%
+665.05K
+209.72%
Mar 31, 2025
Invus Public Equities Advisors, LLC
498.69K
0.46%
-155.03K
-23.72%
Mar 31, 2025
詳細を見る
関連ETF
更新時刻: Sat, Sep 6
更新時刻: Sat, Sep 6
銘柄名
比率
Goldman Sachs MarketBeta Emerging Markets Eqty ETF
0%
Goldman Sachs Innovate Equity ETF
0%
Goldman Sachs MarketBeta Total Internatl Eqty ETF
0%
T Rowe Price Small-Mid Cap ETF
0%
T Rowe Price US Equity Research ETF
0%
Invesco ESG NASDAQ Next Gen 100 ETF
0%
Invesco NASDAQ Next Gen 100 ETF
0%
Goldman Sachs MarketBeta Emerging Markets Eqty ETF
比率0%
Goldman Sachs Innovate Equity ETF
比率0%
Goldman Sachs MarketBeta Total Internatl Eqty ETF
比率0%
T Rowe Price Small-Mid Cap ETF
比率0%
T Rowe Price US Equity Research ETF
比率0%
Invesco ESG NASDAQ Next Gen 100 ETF
比率0%
Invesco NASDAQ Next Gen 100 ETF
比率0%
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
